Company intelligence / Profile preview

Proxima Therapeutics

Alpharetta, Georgia, United States

Ownership: Private
Employees: ~101
Development stage: Other

Overview

Proxima Therapeutics was a healthcare company that developed internal radiation delivery systems for the treatment of solid tumors, with an initial focus on brain and breast cancer. Its marketed products included GliaSite RTS for brain cancer and MammoSite RTS for breast cancer. The company was founded in the mid-1990s and based in Alpharetta, Georgia. Proxima Therapeutics was acquired in 2005, and it does not appear to operate today as an independent active biotech company. Despite the existence of a separate modern biotech now branded Proxima, the exact name "Proxima Therapeutics" most consistently refers to the acquired radiation-delivery company.

Therapeutic areas: Oncology
Modalities: DeviceRadiopharmaceutical
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Proxima Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proxima Therapeutics.

Explore the full profile